首页 | 本学科首页   官方微博 | 高级检索  
     

胸腺因子D对复治肺结核病人免疫指标的影响
引用本文:张金福,高薇薇,贾红艳,高宁. 胸腺因子D对复治肺结核病人免疫指标的影响[J]. 中国防痨杂志, 1997, 0(1)
作者姓名:张金福  高薇薇  贾红艳  高宁
作者单位:北京结核病、胸部肿瘤研究所 101149
摘    要:本文应用胸腺因子D加化疗药物治疗复治肺结核30例,并以单纯化疗药物治疗组25例作对照,以观察胸腺因子D对肺结核病人免疫功能的影响及辅助治疗的疗效。结果显示,胸腺因子D加化疗组治疗3个月后,OKT+3、OKT+4、OKT+8细胞百分率。T+4/T+8及NK细胞活性均显著升高,各种免疫球蛋白水平也趋于恢复,与单纯化疗组相比有显著性差异(P<0.01~0.05)。痰菌阴转率(59.3%)也明显高于对照组(44.0%)。提示胸腺因子D辅助治疗肺结核在提高细胞免疫功能方面有一定价值。

关 键 词:结核  肺/免疫学  胸腺因子D

Effect of Thymic Factor D on Immune subiects in patients with Retreatment pulmonary Tuberculosis
Zhang Jinfu, Gao Weiwei, Jia Hongyan,et al.. Effect of Thymic Factor D on Immune subiects in patients with Retreatment pulmonary Tuberculosis[J]. The Journal of The Chinese Antituberculosis Association, 1997, 0(1)
Authors:Zhang Jinfu   Gao Weiwei   Jia Hongyan  et al.
Affiliation:Zhang Jinfu, Gao Weiwei, Jia Hongyan, et al.
Abstract:We collected 30 cases of retreated pulmonary tuberculosis treated with Thymic Factor D and chemotherapy as treatment group and 25 cases created only with chemotherapy as controls, to observe influence of Thymic Factor D on immune function and the effect in immune combined therapy, The results indicated that in the treatment group, the per-centape of OKT 3. OKT 4. OKT 8 and activity of Natural killer cells was greatly elevated and immunnoglobin levels became normal after three months of treatment, These had apparent difference with the controls ( P< 0. 01 - 0. 05), Sputum nega-tive in treatment group (59. 3%) were higher than that in the controls (44. 0%). It indicated that was of value to treatment of retreated pulmonary tuberculosis at the aspect of improving cellular immune function.
Keywords:Tuberculosis   pulmonary/Immunology Thymic Factor D
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号